AU725756B2 - New 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- AU725756B2 AU725756B2 AU56359/98A AU5635998A AU725756B2 AU 725756 B2 AU725756 B2 AU 725756B2 AU 56359/98 A AU56359/98 A AU 56359/98A AU 5635998 A AU5635998 A AU 5635998A AU 725756 B2 AU725756 B2 AU 725756B2
- Authority
- AU
- Australia
- Prior art keywords
- dihydro
- benzodioxin
- piperidine
- fumarate
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9702360A FR2760014B1 (fr) | 1997-02-27 | 1997-02-27 | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR97/02360 | 1997-02-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5635998A AU5635998A (en) | 1998-09-03 |
| AU725756B2 true AU725756B2 (en) | 2000-10-19 |
Family
ID=9504253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU56359/98A Ceased AU725756B2 (en) | 1997-02-27 | 1998-02-27 | New 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5968954A (enExample) |
| EP (1) | EP0861837B1 (enExample) |
| JP (1) | JPH10237071A (enExample) |
| CN (1) | CN1090627C (enExample) |
| AT (1) | ATE265451T1 (enExample) |
| AU (1) | AU725756B2 (enExample) |
| BR (1) | BR9800763A (enExample) |
| CA (1) | CA2231025C (enExample) |
| DE (1) | DE69823411T2 (enExample) |
| DK (1) | DK0861837T3 (enExample) |
| ES (1) | ES2219853T3 (enExample) |
| FR (1) | FR2760014B1 (enExample) |
| HU (1) | HU224312B1 (enExample) |
| NO (1) | NO314307B1 (enExample) |
| NZ (1) | NZ329853A (enExample) |
| PL (1) | PL190240B1 (enExample) |
| PT (1) | PT861837E (enExample) |
| ZA (1) | ZA981680B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI274750B (en) * | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| NZ535574A (en) | 2001-01-16 | 2006-07-28 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| SE0103650D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| US7504395B2 (en) * | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| JP2005343790A (ja) * | 2002-05-31 | 2005-12-15 | Ajinomoto Co Inc | カルシウムチャネル拮抗薬を含有する医薬組成物 |
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| CA2587749A1 (en) * | 2004-12-08 | 2006-06-15 | Astellas Pharma Inc. | Piperidine derivative and process for producing the same |
| UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
-
1997
- 1997-02-27 FR FR9702360A patent/FR2760014B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-24 PL PL98324982A patent/PL190240B1/pl not_active IP Right Cessation
- 1998-02-25 BR BR9800763-7A patent/BR9800763A/pt not_active Application Discontinuation
- 1998-02-25 JP JP10042716A patent/JPH10237071A/ja active Pending
- 1998-02-26 NO NO19980803A patent/NO314307B1/no unknown
- 1998-02-26 CA CA002231025A patent/CA2231025C/fr not_active Expired - Fee Related
- 1998-02-26 NZ NZ329853A patent/NZ329853A/xx unknown
- 1998-02-26 CN CN98107709A patent/CN1090627C/zh not_active Expired - Fee Related
- 1998-02-26 HU HU9800422A patent/HU224312B1/hu not_active IP Right Cessation
- 1998-02-26 US US09/031,490 patent/US5968954A/en not_active Expired - Fee Related
- 1998-02-27 AT AT98400469T patent/ATE265451T1/de not_active IP Right Cessation
- 1998-02-27 EP EP98400469A patent/EP0861837B1/fr not_active Expired - Lifetime
- 1998-02-27 AU AU56359/98A patent/AU725756B2/en not_active Ceased
- 1998-02-27 DE DE69823411T patent/DE69823411T2/de not_active Expired - Fee Related
- 1998-02-27 ZA ZA981680A patent/ZA981680B/xx unknown
- 1998-02-27 ES ES98400469T patent/ES2219853T3/es not_active Expired - Lifetime
- 1998-02-27 DK DK98400469T patent/DK0861837T3/da active
- 1998-02-27 PT PT98400469T patent/PT861837E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO314307B1 (no) | 2003-03-03 |
| HK1014945A1 (en) | 1999-10-08 |
| NO980803D0 (no) | 1998-02-26 |
| JPH10237071A (ja) | 1998-09-08 |
| HU224312B1 (hu) | 2005-07-28 |
| HUP9800422A1 (hu) | 1999-12-28 |
| ZA981680B (en) | 1998-09-04 |
| CA2231025C (fr) | 2003-09-16 |
| PT861837E (pt) | 2004-07-30 |
| FR2760014A1 (fr) | 1998-08-28 |
| FR2760014B1 (fr) | 1999-04-09 |
| CN1090627C (zh) | 2002-09-11 |
| PL324982A1 (en) | 1998-08-31 |
| NZ329853A (en) | 1999-01-28 |
| DE69823411D1 (de) | 2004-06-03 |
| CA2231025A1 (fr) | 1998-08-27 |
| NO980803L (no) | 1998-08-28 |
| ATE265451T1 (de) | 2004-05-15 |
| ES2219853T3 (es) | 2004-12-01 |
| US5968954A (en) | 1999-10-19 |
| AU5635998A (en) | 1998-09-03 |
| DE69823411T2 (de) | 2005-02-17 |
| EP0861837A1 (fr) | 1998-09-02 |
| CN1194983A (zh) | 1998-10-07 |
| PL190240B1 (pl) | 2005-11-30 |
| HU9800422D0 (en) | 1998-04-28 |
| EP0861837B1 (fr) | 2004-04-28 |
| BR9800763A (pt) | 1999-12-07 |
| DK0861837T3 (da) | 2004-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU731018B2 (en) | New N-aryl piperidine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| NZ286698A (en) | Piperazine, piperidine and 1,2,5,6-tetrahydropyridine derivatives, and pharmaceutical compositions | |
| AU2010290871B2 (en) | Chromone derivatives, a process for their preparation and their therapeutic applications | |
| KR20010024077A (ko) | 치환된 크로만 유도체 | |
| CA2316388C (en) | Tetrahydrobenzindole derivative | |
| US5968954A (en) | 2-aminoindan compounds as 5HT1B antagonists | |
| US6153625A (en) | Indan-1-ol compounds | |
| AU736710B2 (en) | New indanol compounds, a process for their preparation and pharmaceutical compositions containing them | |
| EP1613594B1 (en) | 4-(2-phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors | |
| CN113912601B (zh) | 一类新的咪唑并[1,2-a]吡啶类衍生物、其制备方法及医药用途 | |
| NZ299959A (en) | Indole-2-one derivatives, preparation and medicaments for treating central nervous system diseases | |
| CA2275299C (en) | Indane or dihydroindole derivatives | |
| KR100753905B1 (ko) | Ｎ-치환된-1ｈ-퀴놀린-2,4-디온 화합물, 이의 제조 방법 및이를 포함하는 약학적 조성물 | |
| HK1014945B (en) | 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them | |
| Dukic et al. | Synthesis and Dopaminergic Properties of 3‐and 4‐Substituted 1‐{2‐[5‐(1H‐Benzimidazole‐2‐thione)] ethyl} piperidines and Related Compounds | |
| JP2009514795A (ja) | Ｎ−置換−１ｈ−キノリン−２，４−ジオン化合物、その製造方法及びそれを含む薬学的組成物 | |
| PL190924B1 (pl) | Pochodne indolu i 2,3 - dihydroindolu, kompozycja farmaceutyczna oraz ich zastosowanie | |
| JP2016106072A (ja) | プロペラン誘導体 | |
| HK1014954B (en) | New n-arylpiperidine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| MXPA02006591A (en) | Novel heteroaryl derivatives, their preparation and use | |
| CZ2000947A3 (cs) | Substituované chromanové deriváty |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: LES LABORATOIRES SERVIER Free format text: FORMER OWNER WAS: ADIR ET COMPAGNIE |